# Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities

> **NCT02217501** · PHASE3 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 159 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Acetylsalicylic acid (ASA)

## Key facts

- **NCT ID:** NCT02217501
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2020-01-30
- **Final completion:** 2020-01-30
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02217501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02217501, "Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02217501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*